User profiles for Edgar Llontop
 | Edgar E LlontopPhD Student Universidade de São Paulo Verified email at usp.br Cited by 140 |
Antibacterial T6SS effectors with a VRR-Nuc domain are structure-specific nucleases
…, GG Nicastro, L Mead, EE Llontop… - Elife, 2022 - elifesciences.org
The type VI secretion system (T6SS) secretes antibacterial effectors into target competitors.
Salmonella spp. encode five phylogenetically distinct T6SSs. Here, we characterize the …
Salmonella spp. encode five phylogenetically distinct T6SSs. Here, we characterize the …
The Xanthomonas type IV pilus
Highlights • The role that type IV pili play in Xanthomonas pathogenesis varies from species
to species. • Xanthomonas T4P are regulated via unique molecular mechanisms that differ …
to species. • Xanthomonas T4P are regulated via unique molecular mechanisms that differ …
Toxicity of spike fragments SARS-CoV-2 S protein for zebrafish: A tool to study its hazardous for human health?
…, RRC Rosales, I Todeschini, I Rivero, E Llontop… - Science of The Total …, 2022 - Elsevier
Despite the significant increase in the generation of SARS-CoV-2 contaminated domestic
and hospital wastewater, little is known about the ecotoxicological effects of the virus or its …
and hospital wastewater, little is known about the ecotoxicological effects of the virus or its …
[HTML][HTML] Bactericidal type IV secretion system homeostasis in Xanthomonas citri
Several Xanthomonas species have a type IV secretion system (T4SS) that injects a cocktail
of antibacterial proteins into neighbouring Gram-negative bacteria, often leading to rapid …
of antibacterial proteins into neighbouring Gram-negative bacteria, often leading to rapid …
Zebrafish studies on the vaccine candidate to COVID-19, the Spike protein: Production of antibody and adverse reaction
…, RRC Rosales, I Todeschini, I Rivero, E Llontop… - BioRxiv, 2020 - biorxiv.org
Establishing new experimental animal models to assess the safety and immune response to
the antigen used in the development of COVID-19 vaccine is an imperative issue. Based on …
the antigen used in the development of COVID-19 vaccine is an imperative issue. Based on …
[HTML][HTML] The PilB-PilZ-FimX regulatory complex of the Type IV pilus from Xanthomonas citri
Type IV pili (T4P) are thin and flexible filaments found on the surface of a wide range of
Gram-negative bacteria that undergo cycles of extension and retraction and participate in a …
Gram-negative bacteria that undergo cycles of extension and retraction and participate in a …
Importance of the β5− β6 Loop for the Structure, Catalytic Efficiency, and Stability of Carbapenem-Hydrolyzing Class D β-Lactamase Subfamily OXA-143
The class D β-lactamase OXA-143 has been described as an efficient penicillinase, oxacillinase,
and carbapenemase. The D224A variant, known as OXA-231, was described in 2012 …
and carbapenemase. The D224A variant, known as OXA-231, was described in 2012 …
Antibacterial T6SS effectors with a VRR-Nuc domain induce target cell death via DNA Double-Strand Breaks
…, G Gonçalves Nicastro, L Mead, EE Llontop… - bioRxiv, 2021 - biorxiv.org
The T6SS (Type VI secretion System) secretes antibacterial effectors into target competitors.
Salmonella spp. encode five phylogenetically distinct T6SSs. Here we characterize the …
Salmonella spp. encode five phylogenetically distinct T6SSs. Here we characterize the …
Resource sharing by outer membrane vesicles from a citrus pathogen
…, AD Purificação, I Todeschini, EE Llontop… - BioRxiv, 2021 - biorxiv.org
The causative agent of citrus canker disease, Xanthomonas citri pv. citri, was found to
produce copious amounts of outer membrane vesicles (OMVs), frequently forming long …
produce copious amounts of outer membrane vesicles (OMVs), frequently forming long …
Zebrafish studies on the vaccine candidate to COVID-19, the Spike protein: Production of antibody and adverse reaction (preprint)
…, RRC Rosales, I Todeschini, I Rivero, E Llontop… - 2020 - pesquisa.bvsalud.org
Establishing new experimental animal models to assess the safety and immune response to
the antigen used in the development of COVID-19 vaccine is an imperative issue. Based on …
the antigen used in the development of COVID-19 vaccine is an imperative issue. Based on …